Buchumschlag

Effect of anticancer drugs on breast cancer cells sensitive and resistant to doxorubicin: expression of mRNAs of TGF-β and its receptors

Gespeichert in:

Bibliographische Detailangaben
Datum:	2014
Hauptverfasser:	I. V. Chorna, O. V. Fedorenko, R. S. Stoika
Format:	Artikel
Sprache:	Englisch
Veröffentlicht:	2014
Schriftenreihe:	Biopolymers and Cell
Online Zugang:	http://jnas.nbuv.gov.ua/article/UJRN-0000184304
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!
Назва журналу:	Library portal of National Academy of Sciences of Ukraine \| LibNAS

Institution

Library portal of National Academy of Sciences of Ukraine | LibNAS

Ähnliche Einträge

Effect of anticancer drugs on breast cancer cells sensitive and resistant to doxorubicin: expression of mRNAs of TGF-β and its receptors
von: Chorna, I.V., et al.
Veröffentlicht: (2014)

Fractal dimension of the breast cancer cells resistant and sensitive to doxorubicin activity
von: Medviediev, O., et al.
Veröffentlicht: (2016)

Correlation of iodine symporter expression in highly and low malignant cell lines of human breast cancer differed in their sensitivity to doxorubicin
von: Lukianova, N.Yu., et al.
Veröffentlicht: (2016)

TGF-β1 expression by glioma C6 cells in vitro
von: Liubich, L.D., et al.
Veröffentlicht: (2017)

Sensitivity of chronic lymphocytic leukemia cells to chemotherapeutic drugs ex vivo depends on expression status of cell surface receptors
von: Shcherbina, V., et al.
Veröffentlicht: (2023)

Mechanomagnetic reactor for activation of anticancer drugs
von: V. E. Orel, et al.
Veröffentlicht: (2014)

Impact of combinations of EGF, TGFβ, 17β-oestradiol, and inhibitors of corresponding pathways on proliferation of breast cancer cell lines
von: Mints, M., et al.
Veröffentlicht: (2014)

Effect of anticancer drugs on production of transforming growth factor and expression of P53 and BCL-2 proteins by MCF-7 and T47D cell lines of human breast carcinoma
von: Stoika, R.S., et al.
Veröffentlicht: (2008)

Magnetic characteristics and anticancer activity of a nanocomplex consisting of detonation nanodiamond and doxorubicin
von: V. E. Orel, et al.
Veröffentlicht: (2012)

Tumor microenvironment-derived miRNAs as prognostic markers of breast cancer
von: Lukianova, N.Yu., et al.
Veröffentlicht: (2023)

Prognostic role of androgen receptor expression in patients with metastatic triple negative breast cancer
von: Lyalkin, S.A., et al.
Veröffentlicht: (2023)

Comments on the cross-talk of TGFβ and EGF in cancer
von: Jia, M., et al.
Veröffentlicht: (2011)

Proteomics of transforming growth factor β1 (TGF β1) signaling in 184A1 human breast epithelial cells suggests the involvement of casein kinase 2α in TGF β1-dependent p53 phosphorylation at Ser392
von: Woksepp, H., et al.
Veröffentlicht: (2023)

Effects of IL-6, IL-10 and TGF-β on the expression of survivin and apoptosis in nasopharyngeal carcinoma TW01 cells
von: Poh, Y.W., et al.
Veröffentlicht: (2012)

Magnetic liquids based on magnetite and doxorubicin for targeted drug delivery
von: A. L. Petranovska, et al.
Veröffentlicht: (2015)

Efficacy of anticancer autovaccine with standard anticancer treatmentcombination in breast cancer patients (analysis of 10-year surveillance data)
von: V. V. Zajchuk, et al.
Veröffentlicht: (2015)

Hepcidin as a possible marker in determination of malignancy degree and sensitivity of breast cancer cells to cytostatic drugs
von: Yalovenko, T.M., et al.
Veröffentlicht: (2016)

Ultrastructural changes in tumor cells treated with liposomal forms of anticancer drugs
von: Yurchenko, O.V., et al.
Veröffentlicht: (2010)

Low-density microarray analysis of TGFβ1-dependent cell cycle regulation in human breast adenocarcinoma MCF7 cell line
von: Dubrovska, A.M., et al.
Veröffentlicht: (2014)

Different morphological structures of breast tumors demonstrate individual drug resistance gene expression profiles
von: Gerashchenko, T.S., et al.
Veröffentlicht: (2018)

Comparative study of magnetic properties and the anticancer effect of superparamagnetic and ferromagnetic iron oxide nanoparticles in the nanocomplex with doxorubicin
von: V. E. Orel, et al.
Veröffentlicht: (2015)

Chemocine receptor CXCR4 expression and microvessels density in malignant tumors of the breast of patients with sings of metabolic syndrome
von: N. P. Yurchenko, et al.
Veröffentlicht: (2020)

Effect of 5-azacytidine on mirna expression in human breast cancer cells with different sensitivity to cytostatics
von: Chekhun, V.F., et al.
Veröffentlicht: (2016)

MicroRNAs in normal and cancer cells: a new class of gene expression regulators
von: Bagnyukova, T.V., et al.
Veröffentlicht: (2006)

Effect of 5-azacytidine on miRNA expression in human breast cancer cells with different sensitivity to cytostatics
von: V. F. Chekhun, et al.
Veröffentlicht: (2016)

Thiazolidinone motif in anticancer drug discovery. Experience of DH LNMU medicinal chemistry scientific group
von: Lesyk, R. B., et al.
Veröffentlicht: (2011)

Micellar compositions with doxorubicin and their cytotoxicity
von: L. R. Kunytska, et al.
Veröffentlicht: (2016)

Distribution and accumulation of liposomal form of doxorubicin in breast cancer cells of MCF-7 line
von: Rusetskaya, N.V., et al.
Veröffentlicht: (2011)

The lipid content of cisplatin- and doxorubicin-resistant MCF-7 human breast cancer cells
von: Todor, I.N., et al.
Veröffentlicht: (2012)

Receptor status of tumor as prognostic factor in patients with bilateral breast cancer
von: D. Y. Tsyhyka, et al.
Veröffentlicht: (2013)

Receptor status of tumor as prognostic factor in patients with bilateral breast cancer
von: Tsyhyka, D.Y., et al.
Veröffentlicht: (2013)

MicroRNAs and human cancer
von: Nikitina, E.G., et al.
Veröffentlicht: (2012)

Impact of combinations of EGF, TGF?, 17?-oestradiol, and inhibitors of corresponding pathways on proliferation of breast cancer cell lines
von: M. Mints, et al.
Veröffentlicht: (2014)

Evidence for Consistency of Anticancer Therapy with Cryopreserved Fetal Liver Cells in Experimental Model of Breast Cancer
von: N. A. Bondarovich, et al.
Veröffentlicht: (2012)

mRNAs coding for A1 and A2 isoforms of translation factor eEF1A demonstrate different half-lives while A1 and A2 proteins are similarly stable in MCF7 cells
von: Vislovukh, A.A., et al.
Veröffentlicht: (2013)

mRNAs coding for A1 and A2 isoforms of translation factor eEF1A demonstrate different half-lives while A1 and A2 proteins are similarly stable in MCF7 cells
von: A. A. Vislovukh, et al.
Veröffentlicht: (2013)

TGF-β1 and TNF-α after red blood cell transfusion in colorectal cancer patients
von: Milasiene, V., et al.
Veröffentlicht: (2007)

Features of hepcidin expression in patients with breast cancer
von: Yu. Lukianova, et al.
Veröffentlicht: (2015)

Dihydropyrimidine dehydrogenase activity correlates with fluorouracil sensitivity in breast cancer
von: Yu, Z., et al.
Veröffentlicht: (2007)

Adaptor protein Ruk/CIN85 modulates resistance to doxorubicin of murine 4T1 breast cancer cells
von: I. R. Horak, et al.
Veröffentlicht: (2018)